Brief: PDS Biotech Announces Scheduling Of Type C Meeting With U.S. Food And Drug Administration
02/12/2025 13:34
Dec 2 (Reuters) - PDS Biotechnology Corp PDSB.O: PDS BIOTECH ANNOUNCES SCHEDULING OF TYPE C MEETING WITH U.S. FOOD AND DRUG ADMINISTRATION (“FDA”) PDS BIOTECHNOLOGY CORP - MEETING TO DISCUSS ACCELERATED APPROVAL FOR PDS0101 Source text: ID:nGNX1kMJ0 Further company coverage: PDSB.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on PDS Biotechnology
See all newsPDS Biotechnology Corp reports results for the quarter ended September 30 - Earnings Summary
PDS Biotechnology Q3 net loss narrows on lower R&D costs
PDS Biotechnology Corp expected to post a loss of 10 cents a share - Earnings Preview
Brief: PDS Biotech Announces Initial Closing Of Up To $22.3 Mln PIPE Financing
Brief: Pds Biotechnology Corp - On Aug 6, Approved Reduction In Force To Align Expenses With Strategic Priorities - SEC Filing